Literature DB >> 11940575

Direct involvement of CREB-binding protein/p300 in sequence-specific DNA binding of virus-activated interferon regulatory factor-3 holocomplex.

Wakako Suhara1, Mitsutoshi Yoneyama, Issay Kitabayashi, Takashi Fujita.   

Abstract

Infections of bacteria and viruses induce host defense reactions known as innate responses including the activation of interferon regulatory factor-3 (IRF-3), critical for the activation of type I interferon system. Upon immediate early signals triggered by the infection, IRF-3 is phosphorylated and a homodimer results. The homodimer complexes with the coactivator CREB-binding protein (CBP)/p300 in the nucleus; thus, holocomplex of IRF-3 competent in DNA binding is generated. We showed CBP/p300 to be indispensable for the DNA binding activity of the holocomplex and to aid the binding through direct interaction with the DNA. We demonstrated that p300 binds with the IRF-3 homodimer via a Q-rich domain and that an intact histone acetyltransferase (HAT) domain is indispensable for the DNA binding of the holocomplex along with a CH3 domain, which connects the HAT and Q-rich domains. These results highlight a novel function of CBP/p300: direct involvement in sequence-specific DNA binding. Furthermore, the critical function of these domains in virus-induced gene activation was demonstrated in vivo by using p300 mutants.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11940575     DOI: 10.1074/jbc.M200192200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  PKC alpha regulates Sendai virus-mediated interferon induction through HDAC6 and β-catenin.

Authors:  Jianzhong Zhu; Carolyn B Coyne; Saumendra N Sarkar
Journal:  EMBO J       Date:  2011-09-27       Impact factor: 11.598

2.  Type 1 IFN-independent activation of a subset of interferon stimulated genes in West Nile virus Eg101-infected mouse cells.

Authors:  Joanna A Pulit-Penaloza; Svetlana V Scherbik; Margo A Brinton
Journal:  Virology       Date:  2012-02-03       Impact factor: 3.616

3.  Human rhinovirus attenuates the type I interferon response by disrupting activation of interferon regulatory factor 3.

Authors:  Tao Peng; Swathi Kotla; Roger E Bumgarner; Kurt E Gustin
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  Interferon regulatory factor 3 is necessary for induction of antiviral genes during human cytomegalovirus infection.

Authors:  Victor R DeFilippis; Bridget Robinson; Thomas M Keck; Scott G Hansen; Jay A Nelson; Klaus J Früh
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  p300 is involved in formation of the TBP-TFIIA-containing basal transcription complex, TAC.

Authors:  Dimitra J Mitsiou; Hendrik G Stunnenberg
Journal:  EMBO J       Date:  2003-09-01       Impact factor: 11.598

6.  The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression.

Authors:  Michael M Reily; Carlos Pantoja; Xiaoyu Hu; Yurii Chinenov; Inez Rogatsky
Journal:  EMBO J       Date:  2005-12-15       Impact factor: 11.598

7.  Interferon regulatory factor 1 transactivates expression of human DNA polymerase η in response to carcinogen N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  Hongyan Qi; Huifang Zhu; Meng Lou; Yanfeng Fan; Hong Liu; Jing Shen; Zhongjie Li; Xue Lv; Jianzhen Shan; Lijun Zhu; Y Eugene Chin; Jimin Shao
Journal:  J Biol Chem       Date:  2012-02-24       Impact factor: 5.157

Review 8.  Interaction of hepatitis C virus with the type I interferon system.

Authors:  Friedemann Weber
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

9.  Epstein-Barr virus BGLF4 kinase suppresses the interferon regulatory factor 3 signaling pathway.

Authors:  Jiin-Tarng Wang; Shin-Lian Doong; Shu-Chun Teng; Chung-Pei Lee; Ching-Hwa Tsai; Mei-Ru Chen
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

10.  Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation.

Authors:  Thomas Kuri; Xiaonan Zhang; Matthias Habjan; Luis Martínez-Sobrido; Adolfo García-Sastre; Zhenghong Yuan; Friedemann Weber
Journal:  J Gen Virol       Date:  2009-07-22       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.